Patents by Inventor Juma Bridgewater

Juma Bridgewater has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230364252
    Abstract: The present invention provides improved methods for formulating therapeutic compositions comprising an antibody drug conjugate (“ADC”) that reduce potency variability between batches of ADC and provide for administration of such therapeutic compositions within a narrow intended range.
    Type: Application
    Filed: December 23, 2022
    Publication date: November 16, 2023
    Inventors: Gillian PAYNE, Robert W. HERBST, Juma BRIDGEWATER
  • Patent number: 10603388
    Abstract: The present invention provides improved methods for formulating therapeutic compositions comprising an antibody drug conjugate (“ADC”) that reduce potency variability between batches of ADC and provide for administration of such therapeutic compositions within a narrow intended range.
    Type: Grant
    Filed: August 16, 2017
    Date of Patent: March 31, 2020
    Assignee: ImmunoGen, Inc.
    Inventors: Gillian Payne, Robert W. Herbst, Juma Bridgewater
  • Publication number: 20190365917
    Abstract: The present invention provides improved methods for formulating therapeutic compositions comprising an antibody drug conjugate (“ADC”) that reduce potency variability between batches of ADC and provide for administration of such therapeutic compositions within a narrow intended range.
    Type: Application
    Filed: May 9, 2019
    Publication date: December 5, 2019
    Applicant: ImmunoGen, Inc.
    Inventors: Gillian Payne, Robert W. Herbst, Juma Bridgewater
  • Publication number: 20170348428
    Abstract: The present invention provides improved methods for formulating therapeutic compositions comprising an antibody drug conjugate (“ADC”) that reduce potency variability between batches of ADC and provide for administration of such therapeutic compositions within a narrow intended range.
    Type: Application
    Filed: August 16, 2017
    Publication date: December 7, 2017
    Applicant: ImmunoGen, Inc.
    Inventors: Gillian PAYNE, Robert W. HERBST, Juma BRIDGEWATER
  • Publication number: 20160058884
    Abstract: The present invention provides improved methods for formulating therapeutic compositions comprising an antibody drug conjugate (“ADC”) that reduce potency variability between batches of ADC and provide administration of such therapeutic compositions within a narrow intended range.
    Type: Application
    Filed: September 2, 2015
    Publication date: March 3, 2016
    Applicant: IMMUNOGEN, INC.
    Inventors: Gillian Payne, Robert W. Herbst, Juma Bridgewater